ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 807

$663K Total Retail Price of All Prescriptions

Rank: 47 out of 807

606 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,060 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 668 627 1 1
LEVOTHYROXINE SODIUM 440 401 2 3
AMLODIPINE BESYLATE 411 400 3 5
ATENOLOL 402 396 4 7
LISINOPRIL 399 384 5 2
ATORVASTATIN CALCIUM 295 279 6 11
OMEPRAZOLE 262 229 7 4
METOPROLOL SUCCINATE 259 244 8 13
FUROSEMIDE 234 224 9 6
LOSARTAN POTASSIUM 205 187 10 14
METOPROLOL TARTRATE 193 168 11 8
ZOLPIDEM TARTRATE 192 172 12 23
METFORMIN HCL 184 146 13 12
PREDNISONE 162 140 14 24
GABAPENTIN 158 133 15 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 146 16 28
CITALOPRAM HBR 146 127 17 17
HYDROCODONE-ACETAMINOPHEN 134 122 S3 18 15
TRAZODONE HCL 133 113 19 25
WARFARIN SODIUM 127 124 20 10
SERTRALINE HCL 114 105 21 22
TRIAMTERENE-HCTZ 113 104 22 29
LANTUS SOLOSTAR 108 71 23 42
POTASSIUM CHLORIDE 98 95 24 18
CRESTOR 95 79 25 32
TAMSULOSIN HCL 93 74 26 27
PRAVASTATIN SODIUM 92 76 27 21
LANTUS 86 85 28 45
PEN NEEDLE 83 61 29 63
TRAMADOL HCL 78 58 30 19
FLUTICASONE PROPIONATE 70 69 31 30
DONEPEZIL HCL 69 69 32 31
ALLOPURINOL 67 65 33 26
NOVOLOG FLEXPEN 66 37 34 75
DOXAZOSIN MESYLATE 59 57 35 70
CHLORTHALIDONE 59 58 35 99
CARBIDOPA-LEVODOPA 57 50 37 64
CARVEDILOL 57 57 37 35
MIRTAZAPINE 54 54 39 38
OXYCODONE HCL 53 30 S2 40 53
HUMALOG 51 50 41 124
SPIRONOLACTONE 51 45 41 48
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 43 55
BUMETANIDE 50 42 43 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.